StockData
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

PetVivo Holdings, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$27.79M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2024
Ended Mar 31, 2024
Jun 28, 2024During market hours–––
Q3 FY2024
Ended Dec 31, 2023
Feb 12, 2024During market hours$595.89K$-0.12–
Q2 FY2024
Ended Sep 30, 2023
Nov 14, 2023During market hours$207.37K$-0.28–
Q1 FY2024
Ended Jun 30, 2023
Aug 10, 2023During market hours$117.18K$-0.25–
Q4 FY2023
Ended Mar 31, 2023
Jun 29, 2023During market hours–––
Q3 FY2023
Ended Dec 31, 2022
Feb 9, 2023During market hours–––
Q2 FY2023
Ended Sep 30, 2022
Nov 10, 2022During market hours–––
Q1 FY2023
Ended Jun 30, 2022
Aug 11, 2022During market hours–––
Q3 FY2022
Ended Dec 31, 2021
Feb 10, 2022During market hours–––
Q2 FY2022
Ended Sep 30, 2021
Nov 15, 2021During market hours–––

Press releases

Announcements PetVivo filed with the SEC